USA - New York Stock Exchange - NYSE:GSK - US37733W2044 - ADR
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 943.00M | 748.00M | 879.00M | 1.43B | |||
| Cash Equivalents | 3.30B | 2.75B | 2.00B | 3.72B | 4.27B | |||
| Marketable Securities | 10.00M | 21.00M | 2.25B | 7.00B | 2.91B | |||
| Receivables | 8.30B | 6.93B | 7.40B | 7.12B | 8.03B | |||
| Inventories | 6.12B | 5.67B | 5.50B | 5.15B | 5.78B | |||
| Other Current Assets | 114.00M | 679.00M | 751.00M | 631.00M | 525.00M | |||
| Total Current Assets | 17.84B | 17.00B | 18.64B | 20.77B | 18.67B | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.13B | 10.07B | 9.96B | 9.62B | 10.67B | |||
| Investments And Advances | 1.08B | 1.20B | 1.19B | 1.54B | 2.21B | |||
| Goodwill | 7.12B | 6.98B | 6.81B | 7.05B | 10.55B | |||
| Intangibles | 16.86B | 15.52B | 14.77B | 14.32B | 30.08B | |||
| Other Non-Current Assets | 8.30B | 7.66B | 6.68B | 5.89B | 5.98B | |||
| Total Non-Current Assets | 43.50B | 42.47B | 40.36B | 39.38B | 60.43B | |||
| TOTAL ASSETS | 61.34B | 59.46B | 59.01B | 60.15B | 79.10B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 762.00M | 1.01B | 1.64B | 802.00M | |||
| Current Portion Of LT Debt. | 2.86B | 1.59B | 1.81B | 2.31B | 2.80B | |||
| Accrued Expenses | N/A | 10.37B | 10.71B | 10.59B | 11.19B | |||
| Accounts Payable | 15.68B | 3.46B | 3.72B | 3.87B | 4.54B | |||
| Other Current Liabilities | 2.80B | 5.52B | 3.83B | 4.41B | 4.35B | |||
| Total Current Liabilities | 21.33B | 21.70B | 21.07B | 22.81B | 23.67B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 14.89B | 14.64B | 15.21B | 17.04B | 20.57B | |||
| Deferred Taxes/Income | 390.00M | 382.00M | 311.00M | 289.00M | 3.56B | |||
| Other Non-Current Liabilities | 8.97B | 9.66B | 9.63B | 9.92B | 9.96B | |||
| Total Non-Current Liabilities | 23.86B | 24.09B | 24.59B | 26.74B | 40.38B | |||
| TOTAL LIABILITIES | 45.19B | 45.79B | 45.66B | 49.55B | 64.05B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 11.31B | 9.93B | 9.37B | 6.49B | 10.07B | |||
| Additional Paid In Capital | 3.49B | 3.47B | 3.45B | 3.44B | 3.30B | |||
| Minority Interest | -396.00M | -585.00M | -552.00M | -502.00M | 6.29B | |||
| Common Shares | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | |||
| Other Shareholders' Equity | N/A | -416.00M | -310.00M | -373.00M | -49.00M | |||
| Shares Outstanding | 1.98B | 2.04B | 2.00B | 1.99B | 1.98B | |||
| Tangible Book Value per Share | -1.95 | -2.13 | -2.03 | -2.67 | -6.35 | |||
| Total Shareholders' Equity | 16.15B | 13.67B | 13.35B | 10.60B | 15.05B | |||
| TOTAL LIABILITIES AND EQUITY | 61.34B | 59.46B | 59.01B | 60.15B | 79.10B | |||
| Statistics | ||||||||
| Debt/Equity | 0.92 | 1.13 | 1.21 | 1.76 | 1.42 | |||
| Current Ratio | 0.84 | 0.78 | 0.88 | 0.91 | 0.79 | |||
| Return On Assets (ROA) | 8.96% | 4.33% | 8.35% | 24.87% | 5.54% | |||
| Return On Equity (ROE) | 34.02% | 18.84% | 36.92% | 141.12% | 29.13% | |||
| Return On Invested Capital (ROIC) | 18.16% | 18.21% | 18.38% | 18.57% | 8.81% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 19.79% | 19.62% | 20.63% | 25.61% | 10.10% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 57.12% | 52.90% | 54.56% | 105.03% | 58.84% | |||
All data in GBP , ROIC based on taxRate of 0.14